STEM CELL TREATMENT - AN OVERVIEW

A double-blind, placebo-managed research utilised intravenous allogeneic human MSCs in fifty three post-MI individuals, with identical adverse situations between both equally teams. Ambulatory EKG confirmed lessened episodes of ventricular tachycardia, together with improved forced expiratory volume in one second on pulmonary functionality screenin